adults have taken or are currently taking GLP-1 medication specifically for weight loss
Common side effects include constipation, nausea, and vomiting, for instance
The study found that patients prescribed semaglutide drugs had a statistically elevated risk of developing NAION compared to patients taking other diabetes or weight-loss medications
Shared decision-making, gradual dose titration, patient education, and close monitoring are key strategies to mitigate adverse effects and improve satisfaction
Additional GWAS findings have revealed associations with specific single nucleotide polymorphisms (SNPs) in genes such as IL-2 receptor alpha (IL2RA), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), the IL-2/IL-21 locus, natural killer group 2D (NKG2D), and Ikaros family zinc finger 4 (IKZF4)
Her responsibilities include writing articles and reports, conducting interviews, and supporting the delivery of Informas in-person and online events